Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q85246424 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235823.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q85246424 | ||
| 024 | ‡a 0000-0001-8585-7238 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q85246424 | ||
| 100 | 0 | ‡a Ana Paula de Faria ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Ana Paula de Faria ‡c wetenschapper ‡9 nl | |
| 400 | 0 | ‡a Ana Paula de Faria ‡c investigador ‡9 es | |
| 670 | ‡a Author's A Proposed Inflammatory Score of Circulating Cytokines/Adipokines Associated with Resistant Hypertension, but Dependent on Obesity Parameters | ||
| 670 | ‡a Author's Acute Sildenafil Use Reduces 24-Hour Blood Pressure Levels in Patients With Resistant Hypertension: A Placebo-Controlled, Crossover Trial. | ||
| 670 | ‡a Author's Adipokines: novel players in resistant hypertension. | ||
| 670 | ‡a Author's Combined Aerobic and Resistance Exercises Evokes Longer Reductions on Ambulatory Blood Pressure in Resistant Hypertension: A Randomized Crossover Trial | ||
| 670 | ‡a Author's Does Renal Denervation Fit All Resistant Hypertension? The Role of Genetics. | ||
| 670 | ‡a Author's Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus. | ||
| 670 | ‡a Author's Increased Circulating Tissue Inhibitor of Metalloproteinase-2 Is Associated With Resistant Hypertension. | ||
| 670 | ‡a Author's Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists. | ||
| 670 | ‡a Author's Modulation of aldosterone levels by -344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension | ||
| 670 | ‡a Author's Pro-inflammatory Cytokines and Resistant Hypertension: Potential for Novel Treatments? | ||
| 670 | ‡a Author's White coat syndrome and its variations: differences and clinical impact | ||
| 909 | ‡a (orcid) 0000000185857238 ‡9 1 | ||
| 919 | ‡a proposedinflammatoryscoreofcirculatingcytokinesadipokinesassociatedwithresistanthypertensionbutdependentonobesityparameters ‡A A Proposed Inflammatory Score of Circulating Cytokines/Adipokines Associated with Resistant Hypertension, but Dependent on Obesity Parameters ‡9 1 | ||
| 919 | ‡a acutesildenafilusereduces24hourbloodpressurelevelsinpatientswithresistanthypertensionaplacebocontrolledcrossovertrial ‡A Acute Sildenafil Use Reduces 24-Hour Blood Pressure Levels in Patients With Resistant Hypertension: A Placebo-Controlled, Crossover Trial. ‡9 1 | ||
| 919 | ‡a adipokinesnovelplayersinresistanthypertension ‡A Adipokines: novel players in resistant hypertension. ‡9 1 | ||
| 919 | ‡a combinedaerobicandresistanceexercisesevokeslongerreductionsonambulatorybloodpressureinresistanthypertensionarandomizedcrossovertrial ‡A Combined Aerobic and Resistance Exercises Evokes Longer Reductions on Ambulatory Blood Pressure in Resistant Hypertension: A Randomized Crossover Trial ‡9 1 | ||
| 919 | ‡a doesrenaldenervationfitallresistanthypertensiontheroleofgenetics ‡A Does Renal Denervation Fit All Resistant Hypertension? The Role of Genetics. ‡9 1 | ||
| 919 | ‡a glycatedhemoglobincorrelateswitharterialstiffnessandendothelialdysfunctioninpatientswithresistanthypertensionanduncontrolleddiabetesmellitus ‡A Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus. ‡9 1 | ||
| 919 | ‡a increasedcirculatingtissueinhibitorofmetalloproteinase2isassociatedwithresistanthypertension ‡A Increased Circulating Tissue Inhibitor of Metalloproteinase-2 Is Associated With Resistant Hypertension. ‡9 1 | ||
| 919 | ‡a managingresistanthypertensionfocusonmineralocorticoidreceptorantagonists ‡A Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists. ‡9 1 | ||
| 919 | ‡a modulationofaldosteronelevelsby344100tcyp11b2polymorphismandspironolactoneuseinresistanthypertension ‡A Modulation of aldosterone levels by -344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension ‡9 1 | ||
| 919 | ‡a whitecoatsyndromeanditsvariationsdifferencesandclinicalimpact ‡A White coat syndrome and its variations: differences and clinical impact ‡9 1 | ||
| 919 | ‡a proinflammatorycytokinesandresistanthypertensionpotentialfornoveltreatments ‡A Pro-inflammatory Cytokines and Resistant Hypertension: Potential for Novel Treatments? ‡9 1 | ||
| 996 | ‡2 NUKAT|n 2017020709 | ||
| 996 | ‡2 PTBNP|1887082 | ||
| 996 | ‡2 BLBNB|000557174 | ||
| 996 | ‡2 NUKAT|n 2021160940 | ||
| 996 | ‡2 PTBNP|156243 | ||
| 996 | ‡2 PTBNP|1904034 | ||
| 996 | ‡2 BLBNB|001537474 | ||
| 996 | ‡2 ISNI|0000000070712813 | ||
| 996 | ‡2 SUDOC|113986815 | ||
| 996 | ‡2 SUDOC|102487081 | ||
| 996 | ‡2 BLBNB|001412122 | ||
| 996 | ‡2 BLBNB|000985793 | ||
| 996 | ‡2 NII|DA04714202 | ||
| 996 | ‡2 BLBNB|000425236 | ||
| 996 | ‡2 BIBSYS|1523345890718 | ||
| 996 | ‡2 PTBNP|1147263 | ||
| 996 | ‡2 PTBNP|1746580 | ||
| 996 | ‡2 SUDOC|076383741 | ||
| 996 | ‡2 PTBNP|1470802 | ||
| 996 | ‡2 DNB|1341484645 | ||
| 996 | ‡2 ISNI|0000000070023786 | ||
| 996 | ‡2 ISNI|0000000112613064 | ||
| 996 | ‡2 DNB|1293977012 | ||
| 996 | ‡2 ISNI|0000000084213636 | ||
| 996 | ‡2 PTBNP|1487691 | ||
| 996 | ‡2 ISNI|0000000066630989 | ||
| 996 | ‡2 ISNI|0000000109155023 | ||
| 996 | ‡2 LC|n 95013902 | ||
| 996 | ‡2 PTBNP|1582548 | ||
| 996 | ‡2 PTBNP|1710393 | ||
| 996 | ‡2 RERO|A000137883 | ||
| 996 | ‡2 PTBNP|1627192 | ||
| 996 | ‡2 BLBNB|000519614 | ||
| 996 | ‡2 PTBNP|1276221 | ||
| 996 | ‡2 PTBNP|131748 | ||
| 996 | ‡2 ISNI|0000000070219535 | ||
| 996 | ‡2 LIH|LNB:CO_a_2;=BL | ||
| 996 | ‡2 BLBNB|001458011 | ||
| 996 | ‡2 BIBSYS|90182296 | ||
| 996 | ‡2 JPG|500550334 | ||
| 996 | ‡2 SUDOC|155132350 | ||
| 996 | ‡2 SUDOC|185082122 | ||
| 996 | ‡2 PTBNP|1273178 | ||
| 996 | ‡2 BAV|495_390376 | ||
| 996 | ‡2 PTBNP|1912436 | ||
| 996 | ‡2 LC|no2011129283 | ||
| 996 | ‡2 BNE|XX1317159 | ||
| 996 | ‡2 RERO|A003521832 | ||
| 996 | ‡2 LC|nr 93008908 | ||
| 996 | ‡2 PTBNP|1245228 | ||
| 996 | ‡2 LC|n 2009012514 | ||
| 996 | ‡2 BNF|16978711 | ||
| 996 | ‡2 PTBNP|1866814 | ||
| 996 | ‡2 LC|nr2005006127 | ||
| 996 | ‡2 ISNI|0000000428205470 | ||
| 996 | ‡2 PTBNP|1838206 | ||
| 996 | ‡2 DNB|1261757491 | ||
| 996 | ‡2 PTBNP|1495378 | ||
| 996 | ‡2 J9U|987007383933105171 | ||
| 996 | ‡2 PTBNP|1294844 | ||
| 996 | ‡2 PTBNP|1149363 | ||
| 996 | ‡2 ISNI|0000000068295272 | ||
| 996 | ‡2 PTBNP|1381844 | ||
| 996 | ‡2 BIBSYS|90356745 | ||
| 996 | ‡2 PTBNP|25844 | ||
| 996 | ‡2 PTBNP|25842 | ||
| 996 | ‡2 LC|n 2021028109 | ||
| 996 | ‡2 PTBNP|25840 | ||
| 996 | ‡2 ISNI|0000000068814239 | ||
| 996 | ‡2 ISNI|0000000067809040 | ||
| 996 | ‡2 PTBNP|1267074 | ||
| 996 | ‡2 LC|n 2024250455 | ||
| 996 | ‡2 ISNI|0000000070840751 | ||
| 996 | ‡2 BNF|15107463 | ||
| 996 | ‡2 ISNI|0000000067890651 | ||
| 996 | ‡2 LC|n 2023255067 | ||
| 996 | ‡2 BLBNB|001479477 | ||
| 996 | ‡2 DNB|1245481835 | ||
| 996 | ‡2 BLBNB|001578471 | ||
| 996 | ‡2 PTBNP|1599996 | ||
| 996 | ‡2 ISNI|0000000070638393 | ||
| 996 | ‡2 ISNI|0000000439717658 | ||
| 996 | ‡2 NKC|xx0146158 | ||
| 996 | ‡2 PTBNP|1912450 | ||
| 996 | ‡2 PTBNP|156915 | ||
| 996 | ‡2 BLBNB|001547628 | ||
| 996 | ‡2 ISNI|0000000456268153 | ||
| 996 | ‡2 PTBNP|1210155 | ||
| 996 | ‡2 PTBNP|25850 | ||
| 996 | ‡2 LC|n 82144189 | ||
| 996 | ‡2 PTBNP|1916501 | ||
| 996 | ‡2 ISNI|0000000440135268 | ||
| 996 | ‡2 DNB|1053056885 | ||
| 996 | ‡2 ISNI|0000000070996625 | ||
| 996 | ‡2 SUDOC|077752740 | ||
| 996 | ‡2 LNB|LNC10-000050175 | ||
| 996 | ‡2 PTBNP|1780397 | ||
| 996 | ‡2 NII|DA00686808 | ||
| 996 | ‡2 BLBNB|001458694 | ||
| 996 | ‡2 PTBNP|944445 | ||
| 996 | ‡2 PTBNP|81172 | ||
| 996 | ‡2 J9U|987007314745605171 | ||
| 996 | ‡2 ISNI|0000000069217866 | ||
| 996 | ‡2 PTBNP|26030 | ||
| 996 | ‡2 LC|nr2006004936 | ||
| 996 | ‡2 LC|no2010147720 | ||
| 996 | ‡2 PTBNP|1384557 | ||
| 996 | ‡2 ISNI|0000000067882192 | ||
| 996 | ‡2 LC|n 2024180926 | ||
| 996 | ‡2 ISNI|0000000031578156 | ||
| 996 | ‡2 PTBNP|1546595 | ||
| 996 | ‡2 LC|n 2007206822 | ||
| 996 | ‡2 DNB|1136289666 | ||
| 996 | ‡2 ISNI|0000000114381236 | ||
| 996 | ‡2 ISNI|0000000036178282 | ||
| 996 | ‡2 PTBNP|35427 | ||
| 996 | ‡2 PTBNP|35781 | ||
| 996 | ‡2 BLBNB|000298268 | ||
| 996 | ‡2 ISNI|0000000069415918 | ||
| 996 | ‡2 PTBNP|142089 | ||
| 996 | ‡2 PTBNP|1667992 | ||
| 996 | ‡2 BLBNB|000189578 | ||
| 996 | ‡2 ISNI|0000000069799421 | ||
| 996 | ‡2 DNB|1230420851 | ||
| 996 | ‡2 SUDOC|221080147 | ||
| 996 | ‡2 NUKAT|n 2011141023 | ||
| 996 | ‡2 SUDOC|182384004 | ||
| 996 | ‡2 LC|nb2017006904 | ||
| 996 | ‡2 DNB|1011260980 | ||
| 996 | ‡2 PTBNP|1355535 | ||
| 996 | ‡2 PTBNP|25879 | ||
| 996 | ‡2 LC|no2020114773 | ||
| 996 | ‡2 LC|n 2016008437 | ||
| 996 | ‡2 ISNI|0000000486388551 | ||
| 996 | ‡2 BLBNB|001125394 | ||
| 996 | ‡2 NKC|jo20181011777 | ||
| 996 | ‡2 ISNI|000000006869103X | ||
| 996 | ‡2 CAOONL|ncf10665225 | ||
| 996 | ‡2 PTBNP|25881 | ||
| 996 | ‡2 DNB|1036864138 | ||
| 996 | ‡2 NTA|291563619 | ||
| 996 | ‡2 ISNI|0000000118800899 | ||
| 996 | ‡2 DNB|1213674271 | ||
| 996 | ‡2 PTBNP|1867667 | ||
| 996 | ‡2 LC|n 84034129 | ||
| 996 | ‡2 BLBNB|001473610 | ||
| 996 | ‡2 ISNI|0000000070102273 | ||
| 996 | ‡2 J9U|987007273875305171 | ||
| 996 | ‡2 LC|n 2014206858 | ||
| 996 | ‡2 BNF|14176337 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
